Journal of diabetes and its complicationsHumansDiabetes MellitusType 2Sodium-Glucose Transporter 2 InhibitorsFrail Elderly
Criteria of frail older people with type 2 diabetes who are suitable for SGLT-2 inhibitors and GLP-1RA therapy.
A H Abdelhafiz, I Siqueira, A J Sinclair
Published: 202510.1016/j.jdiacomp.2025.109193
Abstract
Frailty is a metabolically heterogeneous condition and therefore, frail older people with diabetes are metabolically diverse. Diversity is caused by the varying degrees of insulin resistance, determined by the variability in muscle mass/visceral fat…
Preview only. Read the full abstract at the source